KPV
Lysine-Proline-Valine
A tripeptide derived from alpha-MSH with potent anti-inflammatory and immune-modulating properties. Gaining attention for gut inflammation and autoimmune conditions.
How KPV Works
KPV is a C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone (alpha-MSH). It exerts potent anti-inflammatory effects by entering cells and interacting directly with inflammatory signaling pathways, particularly by inhibiting NF-kB activation and reducing the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta). Unlike the full alpha-MSH molecule, KPV does not cause skin pigmentation changes, making it a targeted anti-inflammatory agent particularly valued for gut inflammation and autoimmune-related conditions.
📊 Evidence by Outcome
Promising data for IBD and colitis. Anti-inflammatory mechanism well-characterized.
8 studies • Consistency: Moderate • Effect: Moderate
Downregulates inflammatory cytokines without immunosuppression.
6 studies • Consistency: Moderate • Effect: Moderate
Key Research
Peer-Reviewed Evidence • 3 Citations
Anti-inflammatory effects of alpha-MSH-derived peptide KPV
Brzoska T et al.•J Invest Dermatol•2008•PMID: 18200056
Key Finding: KPV tripeptide retains full anti-inflammatory activity of alpha-MSH, inhibiting NF-kB activation and inflammatory cytokine production.
View on PubMedKPV nanoparticles effectively reduce intestinal inflammation in murine colitis models
Dalmasso G et al.•PLoS One•2013•PMID: 23776404
Key Finding: Orally administered KPV nanoparticles significantly reduced colitis severity, demonstrating targeted anti-inflammatory action in the gut.
View on PubMedAlpha-melanocyte-stimulating hormone and related tripeptides: Biochemistry and anti-inflammatory potential
Catania A et al.•Pharmacol Rev•2004•PMID: 15317906
Key Finding: Alpha-MSH peptides including KPV show potent anti-inflammatory properties via melanocortin receptors with therapeutic potential for IBD.
View on PubMedCitations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
Side Effects & Safety
Interactions & Contraindications
Drug Interactions
- •May interact with immunosuppressants (KPV has potent anti-inflammatory and immunomodulatory effects)
- •Theoretical interaction with TNF-alpha inhibitors (overlapping anti-inflammatory mechanism)
- •No well-documented pharmaceutical interactions
Supplement Interactions
- •Synergistic with BPC-157 for gut inflammation and IBD protocols
- •Compatible with glutamine and zinc carnosine for gut barrier support
- •May complement curcumin for systemic anti-inflammatory effects
Food & Timing
- •Oral form best taken on an empty stomach for gut-targeted benefits
- •No known food interactions
- •Can be used with or without food when targeting systemic inflammation
Who Should Avoid
- •Active or history of melanoma (KPV is derived from alpha-MSH, which acts on melanocortin receptors involved in melanocyte activity)
- •Pregnancy and breastfeeding (insufficient safety data)
- •Children under 18
- •Individuals on multiple immunosuppressive therapies
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Cost Guide
AED 400-1,000/month
Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.
Frequently Asked Questions
KPV is available through select wellness clinics and compounding pharmacies in the UAE, particularly those specializing in peptide therapies and gut health. Availability may be more limited than mainstream peptides like BPC-157.
For gut inflammation, many users report improvement within 2-4 weeks. Skin conditions may take 4-8 weeks. Chronic inflammatory conditions may require 2-3 months of consistent use.
Yes, oral KPV is specifically used for targeting gut inflammation, IBD, and intestinal permeability. The oral route delivers the peptide directly to the intestinal lining where it can act on inflamed tissue. Capsule or liquid forms are available.
No. Unlike the full alpha-MSH peptide (or melanotan), KPV does not activate melanocortin-1 receptors responsible for pigmentation. It retains the anti-inflammatory properties of alpha-MSH without the tanning effect.
Where to Get It (UAE)
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, safety, accessibility, and value — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.